Publication
Recommendations for LDLR variant interpretation by the ClinGen’s Familial Hypercholesterolemia Expert Panel
| dc.contributor.author | Chora, J.R. | |
| dc.contributor.author | Iacocca, M. | |
| dc.contributor.author | Tichy, L. | |
| dc.contributor.author | Wand, H. | |
| dc.contributor.author | Kurtz, L.C. | |
| dc.contributor.author | Zimmermann, H. | |
| dc.contributor.author | Meredith, A.L. | |
| dc.contributor.author | Williams, M. | |
| dc.contributor.author | Humphries, S.E. | |
| dc.contributor.author | Hooper, A.J. | |
| dc.contributor.author | Brunham, L. | |
| dc.contributor.author | Pereira, A.C. | |
| dc.contributor.author | Chen, M. | |
| dc.contributor.author | Wang, J. | |
| dc.contributor.author | Trinder, M. | |
| dc.contributor.author | Jannes, C.E. | |
| dc.contributor.author | Chonis, J. | |
| dc.contributor.author | Kim, S. | |
| dc.contributor.author | Pesaran, T. | |
| dc.contributor.author | Johnston, T. | |
| dc.contributor.author | Carrie, A. | |
| dc.contributor.author | Leigh, S. | |
| dc.contributor.author | Hegele, R.A. | |
| dc.contributor.author | Sijbrands, E. | |
| dc.contributor.author | Freiberger, T. | |
| dc.contributor.author | Knowles, J.W. | |
| dc.contributor.author | Bourbon, M. | |
| dc.date.accessioned | 2021-04-30T15:07:10Z | |
| dc.date.available | 2021-04-30T15:07:10Z | |
| dc.date.issued | 2020-11 | |
| dc.description.abstract | Familial Hypercholesterolemia (FH): - Lipid metabolism autosomal dominant condition; - Elevated low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) values since childhood → increased risk of atherosclerotic cardiovascular disease; - High heterozygote prevalence (1/250-1/500); Homozygous rare (1/ 300 000- 1/ 1 000 000); - Caused by pathogenic variants in LDLR (>90%), APOB (5- 10%) and PCSK9 (1-3%) genes; -Marked increase in FH variants submitted to ClinVar; -45% of variants were classified with more than one method and 466 variants submitted with potential clinical significance had conflicting or no classifications. | pt_PT |
| dc.description.version | N/A | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.18/7716 | |
| dc.language.iso | eng | pt_PT |
| dc.publisher | Instituto Nacional de Saúde Doutor Ricardo Jorge, IP | pt_PT |
| dc.subject | Familial Hypercholesterolemia | pt_PT |
| dc.subject | Recommendations | pt_PT |
| dc.subject | LDLR Variant | pt_PT |
| dc.subject | Doenças Cardio e Cérebro-vasculares | pt_PT |
| dc.title | Recommendations for LDLR variant interpretation by the ClinGen’s Familial Hypercholesterolemia Expert Panel | pt_PT |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.title | 24th Annual Meeting of the Portuguese Society of Human Genetics. Virtual Meeting, November 20, 2020 | pt_PT |
| rcaap.rights | embargoedAccess | pt_PT |
| rcaap.type | conferenceObject | pt_PT |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Recommendations for LDLR variant interpretation by the ClinGen’s Familial Hypercholesterolemia Expert Panel..pdf
- Size:
- 931.15 KB
- Format:
- Adobe Portable Document Format
